Predictive value of microenvironment for progression in breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Goto, Wataru [1 ]
Kashiwagi, Shinichiro [1 ]
Asano, Yuka [1 ]
Takada, Koji [1 ]
Takahashi, Katsuyuki [2 ]
Noda, Satoru [1 ]
Takashima, Tsutomu [1 ]
Onoda, Naoyoshi [1 ]
Tomita, Shuhei [2 ]
Hirakawa, Kosei [1 ]
Ohira, Masaichi [1 ]
机构：
[1] Osaka City Univ, Sch Med, Dept Surg Oncol, Osaka, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Pharmacol, Osaka, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Breast cancer; Tumor Immunity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-1033
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Nataliya Babyshkina
    Marina Zavyalova
    Natalia Tarabanovskaya
    Tatyana Dronova
    Nadejda Krakhmal
    Elena Slonimskaya
    Julia Kzhyshkowska
    Evgeny Choynzonov
    Nadejda Cherdyntseva
    [J]. Molecular and Cellular Biochemistry, 2018, 444 : 197 - 206
  • [42] Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer
    Kneubil, M. C.
    Goulart, K. O. B.
    Brollo, J.
    Coelho, G. P.
    Mandelli, J.
    Orlandin, B. C.
    Corso, L. L.
    Roesch-Ely, M.
    Henriques, J. A. P.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2022, 55 (01)
  • [43] Predictive Value of Pretreatment Neutrophil to Albumin Ratio in Response to Neoadjuvant Chemotherapy of Breast Cancer
    Deng, Yu-Xiang
    Zhao, Yu-Jie
    Nong, Qiao-Hong
    Qiu, Hong-Mei
    Guo, Qiao-Li
    Hu, Hui
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 393 - 402
  • [44] Predictive value of IHC4 score for response to neoadjuvant chemotherapy in breast cancer
    Elsamany, S.
    Elmorsy, S.
    Alzahrani, A.
    Rasmy, A.
    Abozeed, W.
    Mohammed, A. A.
    Ateia, M.
    Abbas, M. M.
    Mashhour, M.
    [J]. BREAST, 2015, 24 : S91 - S92
  • [45] PARP expression in early breast cancer and its predictive value for response to neoadjuvant chemotherapy
    Loibl, S.
    Mueller, B.
    Von Minckwitz, G.
    Blohmer, J. U.
    Bois, A. D.
    Huober, J. B.
    Fend, F.
    Budczies, J.
    Denkert, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy
    Tanaka, Y
    Maeda, H
    Ogawa, Y
    Nishioka, A
    Itoh, S
    Kubota, K
    Ue, H
    Nakatani, K
    Sasaguri, S
    [J]. ONCOLOGY REPORTS, 2006, 15 (04) : 927 - 931
  • [47] Management of axillary staging in breast cancer patients treated with neoadjuvant chemotherapy
    Sbaity, Eman, III
    Cody, Hiram S.
    [J]. BREAST CANCER MANAGEMENT, 2013, 2 (06) : 499 - 505
  • [48] Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
    Ortolan, E.
    Appierto, V
    Silvestri, M.
    Miceli, R.
    Veneroni, S.
    Folli, S.
    Pruneri, G.
    Vingiani, A.
    Belfiore, A.
    Cappelletti, V
    Vismara, M.
    Dell'Angelo, F.
    De Cecco, L.
    Bianchi, G., V
    de Braud, F. G.
    Daidone, M. G.
    Di Cosimo, S.
    [J]. ESMO OPEN, 2021, 6 (02)
  • [49] Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
    Zheng, Yi-Zi
    Li, Jia-Ying
    Ning, Lv-Wen
    Xie, Ni
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 475 - 487
  • [50] The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer
    Pieper, Willi
    Ignatov, Atanas
    Kalinski, Thomas
    Haybaeck, Johannes
    Czapiewski, Piotr
    Nass, Norbert
    [J]. CANCER BIOMARKERS, 2021, 32 (02) : 161 - 173
12345